CH673395A5 - - Google Patents

Download PDF

Info

Publication number
CH673395A5
CH673395A5 CH350/87A CH35087A CH673395A5 CH 673395 A5 CH673395 A5 CH 673395A5 CH 350/87 A CH350/87 A CH 350/87A CH 35087 A CH35087 A CH 35087A CH 673395 A5 CH673395 A5 CH 673395A5
Authority
CH
Switzerland
Prior art keywords
diclofenac
salt
dry preparation
micronized
pharmaceutically acceptable
Prior art date
Application number
CH350/87A
Other languages
German (de)
English (en)
Inventor
Leo Dr Geller
Peter Glanzmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CH350/87A priority Critical patent/CH673395A5/de
Priority to MYPI88000041A priority patent/MY102662A/en
Priority to SE8800228A priority patent/SE8800228L/
Priority to IL85190A priority patent/IL85190A0/xx
Priority to YU00154/88A priority patent/YU15488A/xx
Priority to LU87115A priority patent/LU87115A1/de
Priority to DE3802357A priority patent/DE3802357A1/de
Priority to GB8801737A priority patent/GB2201089B/en
Priority to FI880368A priority patent/FI880368A/fi
Priority to PH36414A priority patent/PH23652A/en
Priority to FR888800972A priority patent/FR2611498B1/fr
Priority to NZ223343A priority patent/NZ223343A/xx
Priority to CA000557536A priority patent/CA1305058C/en
Priority to PT86644A priority patent/PT86644B/pt
Priority to JP63016006A priority patent/JPS63192716A/ja
Priority to AU11102/88A priority patent/AU612343B2/en
Priority to KR1019880000740A priority patent/KR880008808A/ko
Priority to AT0018588A priority patent/AT397460B/de
Priority to GR880100041A priority patent/GR880100041A/el
Priority to NO880403A priority patent/NO880403L/no
Priority to DK045588A priority patent/DK45588A/da
Priority to IE25088A priority patent/IE60453B1/en
Priority to ES8800262A priority patent/ES2008420A6/es
Priority to BE8800109A priority patent/BE1000442A4/fr
Priority to ZA88638A priority patent/ZA88638B/xx
Priority to NL8800231A priority patent/NL8800231A/nl
Priority to IT47557/88A priority patent/IT1224241B/it
Publication of CH673395A5 publication Critical patent/CH673395A5/de
Priority to US08/017,366 priority patent/US5283067A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)
CH350/87A 1987-01-30 1987-01-30 CH673395A5 (fi)

Priority Applications (28)

Application Number Priority Date Filing Date Title
CH350/87A CH673395A5 (fi) 1987-01-30 1987-01-30
MYPI88000041A MY102662A (en) 1987-01-30 1988-01-19 Parenteral suspensions
SE8800228A SE8800228L (sv) 1987-01-30 1988-01-25 Parenterala suspensioner
IL85190A IL85190A0 (en) 1987-01-30 1988-01-25 Parenteral suspension of diclofenac
YU00154/88A YU15488A (en) 1987-01-30 1988-01-27 Process for preparing dry compound suitable for preparing stable water suspension of diclophenac in salt form
LU87115A LU87115A1 (fr) 1987-01-30 1988-01-27 Parenterale suspensionen
DE3802357A DE3802357A1 (de) 1987-01-30 1988-01-27 Parenterale suspensionen
GB8801737A GB2201089B (en) 1987-01-30 1988-01-27 Parenteral suspensions of diclofenac.
FI880368A FI880368A (fi) 1987-01-30 1988-01-27 Parenterala suspensioner.
PH36414A PH23652A (en) 1987-01-30 1988-01-27 Prenteral suspensions
PT86644A PT86644B (pt) 1987-01-30 1988-01-28 Processo para a preparacao de formulacoes secas contendo um sal de diclofenac
NZ223343A NZ223343A (en) 1987-01-30 1988-01-28 Dry formulations for the preparation of aqueous stable suspension for the parental administration of o-(2,6-dichloroanilino)phenylacetic acid (diclofenac)
CA000557536A CA1305058C (en) 1987-01-30 1988-01-28 Parenteral suspension containing diclofenac
FR888800972A FR2611498B1 (fr) 1987-01-30 1988-01-28 Composition therapeutique seche a base de sel de diclofenac
JP63016006A JPS63192716A (ja) 1987-01-30 1988-01-28 非経口投与用懸濁液
NO880403A NO880403L (no) 1987-01-30 1988-01-29 Parenterale suspensjoner.
ES8800262A ES2008420A6 (es) 1987-01-30 1988-01-29 Procedimiento de obtencion de un preparado seco adecuado para la fabricacion de una suspension acuosa de una sal de diclofenac
AT0018588A AT397460B (de) 1987-01-30 1988-01-29 Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
GR880100041A GR880100041A (el) 1987-01-30 1988-01-29 Παρεντερικα εναιωρηματα.
AU11102/88A AU612343B2 (en) 1987-01-30 1988-01-29 A dry formulation for the preparation of a suspension of diclofenac in salt form; and a stable suspension produced therefrom
DK045588A DK45588A (da) 1987-01-30 1988-01-29 Parenterale suspensioner
IE25088A IE60453B1 (en) 1987-01-30 1988-01-29 Parenteral suspensions of diclofenac
KR1019880000740A KR880008808A (ko) 1987-01-30 1988-01-29 비경구투여용 현탁액
BE8800109A BE1000442A4 (fr) 1987-01-30 1988-01-29 Composition therapeutique seche a base de sel de diclofenac.
ZA88638A ZA88638B (en) 1987-01-30 1988-01-29 Parenteral suspensions
NL8800231A NL8800231A (nl) 1987-01-30 1988-01-29 Parenterale suspensies.
IT47557/88A IT1224241B (it) 1987-01-30 1988-08-21 Praparato secco per sospensioni parentali, procedimento per produrlo e suo impiego
US08/017,366 US5283067A (en) 1987-01-30 1993-02-11 Parenteral suspensions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH350/87A CH673395A5 (fi) 1987-01-30 1987-01-30

Publications (1)

Publication Number Publication Date
CH673395A5 true CH673395A5 (fi) 1990-03-15

Family

ID=4185019

Family Applications (1)

Application Number Title Priority Date Filing Date
CH350/87A CH673395A5 (fi) 1987-01-30 1987-01-30

Country Status (26)

Country Link
JP (1) JPS63192716A (fi)
KR (1) KR880008808A (fi)
AT (1) AT397460B (fi)
AU (1) AU612343B2 (fi)
BE (1) BE1000442A4 (fi)
CA (1) CA1305058C (fi)
CH (1) CH673395A5 (fi)
DE (1) DE3802357A1 (fi)
DK (1) DK45588A (fi)
ES (1) ES2008420A6 (fi)
FI (1) FI880368A (fi)
FR (1) FR2611498B1 (fi)
GB (1) GB2201089B (fi)
GR (1) GR880100041A (fi)
IE (1) IE60453B1 (fi)
IT (1) IT1224241B (fi)
LU (1) LU87115A1 (fi)
MY (1) MY102662A (fi)
NL (1) NL8800231A (fi)
NO (1) NO880403L (fi)
NZ (1) NZ223343A (fi)
PH (1) PH23652A (fi)
PT (1) PT86644B (fi)
SE (1) SE8800228L (fi)
YU (1) YU15488A (fi)
ZA (1) ZA88638B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (fi) * 1988-03-25 1990-10-15 Ciba Geigy Ag
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
FR2793418B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
GB0207529D0 (en) * 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1373913A (en) * 1970-12-17 1974-11-13 Glaxo Lab Ltd Pharmaceutical compositions
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5002940A (en) * 1984-11-06 1991-03-26 Ciba-Geigy Corporation Solid drug formulations and stable suspensions
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung

Also Published As

Publication number Publication date
PT86644A (pt) 1988-02-01
NZ223343A (en) 1990-03-27
NL8800231A (nl) 1988-08-16
PH23652A (en) 1989-09-27
AT397460B (de) 1994-04-25
ZA88638B (en) 1989-10-25
FI880368A (fi) 1988-07-31
FR2611498B1 (fr) 1991-06-14
NO880403L (no) 1988-08-01
KR880008808A (ko) 1988-09-13
NO880403D0 (no) 1988-01-29
MY102662A (en) 1992-08-17
DK45588A (da) 1988-07-31
PT86644B (pt) 1992-01-31
DE3802357A1 (de) 1988-08-11
IT1224241B (it) 1990-09-26
SE8800228L (sv) 1988-07-31
YU15488A (en) 1989-10-31
SE8800228D0 (sv) 1988-01-25
CA1305058C (en) 1992-07-14
BE1000442A4 (fr) 1988-12-06
GR880100041A (el) 1988-12-16
AU1110288A (en) 1988-08-04
AU612343B2 (en) 1991-07-11
IE60453B1 (en) 1994-07-13
FR2611498A1 (fr) 1988-09-09
JPS63192716A (ja) 1988-08-10
IE880250L (en) 1988-07-30
GB2201089A (en) 1988-08-24
GB8801737D0 (en) 1988-02-24
LU87115A1 (fr) 1989-03-08
IT8847557A0 (it) 1988-08-21
GB2201089B (en) 1990-05-16
FI880368A0 (fi) 1988-01-27
ES2008420A6 (es) 1989-07-16
DK45588D0 (da) 1988-01-29
ATA18588A (de) 1993-09-15

Similar Documents

Publication Publication Date Title
DE69609834T2 (de) Kontinuierliche mikrodispersionen von fluorierten verbindungen zur verabreichung von pharmazeutischen stoffen
US5314685A (en) Anhydrous formulations for administering lipophilic agents
EP0733358A2 (de) Intravenös applizierbare Nanosuspensionen
DE69734742T2 (de) Arzneizusammensetzungen enthaltend Ascomycinderivate
DE3853191T2 (de) Arzneimittelträger.
KR970005171B1 (ko) 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제
EP0711556A1 (de) Intravenöse Lösungen für ein Staurosporinderivat
EP1477166B1 (de) Verwendung von Riluzole kombiniert mit geeigneten Hilfs-und Zusatzstoffen zur Behandlung von Krankheiten, die durch eine Hyperproliferation von Keratinozyten gekennzeichnet sind, insbesondere Neurodermitis und Psoriasis
US5283067A (en) Parenteral suspensions
JP2012116860A (ja) ミセル
BRPI0510778B1 (pt) Composição farmacêutica, processo para preparação da :mesma, e, uso de uma composição
EP0233849B1 (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
CH668913A5 (de) Nasale pharmazeutische zusammensetzungen.
CH673395A5 (fi)
JPS62270521A (ja) フルルビプロフエン眼投与製剤
CH684308A5 (de) Liposomen enthaltend ein Allylamin.
JP2019510048A (ja) 週１回又は隔週１回の投与に適したリラグルチドの粘弾性ゲル
EP0277462B1 (de) Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin.
DE69130832T2 (de) Injizierbare amphotericin b enthaltende dispersion
FI99080C (fi) Menetelmä ruoansulatuskanavan ulkopuoliseen annosteluun tarkoitettujen emulsioiden valmistamiseksi
WO1997021428A1 (de) Cortisolspray zur topischen verabreichung
EP0181287A2 (de) Trockensubstanzen und stabile Suspensionen
EP0451103B1 (de) Parenteral applizierbare Liposomenformulierung aus synthetischen Lipiden
US20190231688A1 (en) Method of administering emulsion formulations of an nk-1 receptor antagonist
DE69926633T2 (de) Injizierbare arzneiformulierungen von partricin derivaten

Legal Events

Date Code Title Description
PL Patent ceased